HÁ ALGO NOVO NO RECONHECIMENTO MOLECULAR APLICADO À QUÍMICA MEDICINAL?
AUTOR(ES)
Fokoue, Harold H.; Pinheiro, Pedro S. M.; Fraga, Carlos A. M.; Sant’Anna, Carlos M. R.
FONTE
Quím. Nova
DATA DE PUBLICAÇÃO
2020-01
RESUMO
In Medicinal Chemistry, the knowledge, the study and the understanding of the intermolecular interactions inherent to the molecular recognition of a ligand by its target bioreceptor are essential. This is because understanding these interactions, which define the molecular complementarity between the two, is the key to analyze critically structure-activity relationship studies, allowing the optimization of the modulation of a target bioreceptor by a ligand. Thus, it is necessary the constant study and analysis of intermolecular interactions related to the ligand-bioreceptor complexes. In general, these interactions are all electrostatic in nature, being traditionally classified into two large groups, the electrostatic forces themselves (such as those present in ion-dipole or ion-ion interactions) and van der Waals forces. Despite being well known, theoretical and experimental studies have revealed an increasing number of interactions mediated by these forces. This work presents and discusses intermolecular interactions considering “classical interactions” and “new interactions” in the context of Medicinal Chemistry, taking into account their current definitions, some theoretical principles of each interaction and addressing examples in which these interactions were important for complementarity between a ligand and a biorreceptor.
Documentos Relacionados
- Purely medicinal?
- Terapia de ressincronização cardíaca: há algo de novo no front?
- Há algo novo a se dizer sobre as relações raciais no Brasil contemporâneo?
- Há algo de novo no front : a participação do Brasil na Segunda Guerra Mundial
- A ascensão da China à condição de potência econômica : há algo de novo no "modelo asiático"?